Atlas Trials

The Effect of HMG-CoA Reductase Inhibition on Postprandial GLP-1 Secretion

Clinical trial NCT03018444 · COMPLETED

Trial details

NCT number
NCT03018444
Sponsor
University Hospital, Gentofte, Copenhagen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Hydroxymethylglutaryl-CoA Reductase Inhibitors
Start date
2016-10-01
Primary completion
2017-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.